A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers
Lee A. O’Brien(University of Wisconsin–Madison), David Lillicrap(Queen's University), Kerry Benford(Queen's University), Carol Hegadorn(Queen's University), Hanna Viktória Rácz(Queen's University), Christine Hough(Queen's University), D. RAPSON(Queen's University), Jeffrey J. Sutherland(Dalhousie University)
Cited by 26
Related Papers
The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study
|Blood|2006|351
A Comparison of Methods for Modeling Quantitative Structure−Activity Relationships
|Journal of Medicinal Chemistry|2004|233
Spline-Fitting with a Genetic Algorithm: A Method for Developing Classification Structure−Activity Relationships
|Journal of Chemical Information and Computer Sciences|2003|198
Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study
|Journal of Thrombosis and Haemostasis|2006|86